Data / Drug companies / Nestmann Pharma GmbH
Nestmann Pharma GmbH: 18 products in the FDA NDC directory, labeler code 60295
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Nestmann Pharma GmbH (labeler code 60295) lists 18 products in the FDA National Drug Code Directory. By type: 18 drugs for further processing. Its main marketing category is drugs for further processing. The newest product started marketing on August 21, 2024.
The request: Watch Nestmann Pharma GmbH (FDA labeler code 60295): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 60295
- Products in commercial distribution
- 18
- Packages
- 18
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- March 1, 1992
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 18 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 18 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 15 | 83.3% |
| Tablet, orally disintegrating | 2 | 11.1% |
| Spray | 1 | 5.6% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Aconitum napellus, bryonia cretica | 60295-0111 | Liquid | Drugs for further processing | August 21, 2024 |
| Aconitum napellus, atropa belladonna, chamomilla recutita | 60295-0113 | Liquid | Drugs for further processing | July 18, 2024 |
| Aconitum napellus, atropa belladonna, bryonia cretica | 60295-0112 | Liquid | Drugs for further processing | July 18, 2024 |
| Hydrastis canadensis, lycopodium clavatum, ephedra vulgaris, mezereum, petroleum, pulsatilla, thuja occidentalis | 60295-0315 | Spray | Drugs for further processing | September 12, 2022 |
| Polygonum aviculare, acorus calamus, rhus toxicodendron, gnaphalium polycephalum, rhododendron chrysanthum, colocynthis, colchicum autumnale, kali iodatum, ichthyolum, symphytum officinale | 60295-5304 | Liquid | Drugs for further processing | June 14, 2022 |
| Alchemilla vulgaris, asperula odorata, chamomilla, viola odorata, cinchona officinalis, mentha piperita, rosmarinus officinalis, valeriana officinalis, helonia dioica, agnus castus, ambra grisea, cimicifuga racemosa, convallaria majalis, crocus sativus, cyclamen europaeum, damiana, hydrastis canadensis, caulophyllum thalictroides, lilium tigrinum, senecio aureus, staphysagria, naja tripudians | 60295-5317 | Liquid | Drugs for further processing | March 1, 1992 |
| Cactus grandiflorus, convallaria majalis, crataegus laevigata, camphora, kalmia latifolia, spigelia anthelmia, lachesis mutus, arnica montana,tabacum, glonoinum | 60295-5311 | Liquid | Drugs for further processing | March 1, 1992 |
| Potentilla anserina, aesculus hippocastanum, ustilago maidis, secale cornutum, ruta graveolens | 60295-5302 | Liquid | Drugs for further processing | March 1, 1992 |
| Solidago virgaurea, uva-ursi, pareira brava, sabal serrulata, populus tremuloides, staphysagria, cantharis, terebinthia, borax | 60295-5301 | Liquid | Drugs for further processing | March 1, 1992 |
| Luffa, hydrastis canadensis, mercurius sulph. rub, allium cepa, natrum muriticum, phosphorus, eupatorium perf, sticta | 60295-5101 | Tablet, orally disintegrating | Drugs for further processing | March 1, 1992 |
| Lithium bromatum | 60295-5019 | Liquid | Drugs for further processing | March 1, 1992 |
| Lycopus virginicus, spongia tosta, lophophytum leandrii, chininum arsenicosum, calcarea phosphorica, magnesia phosphorica | 60295-0313 | Liquid | Drugs for further processing | March 1, 1992 |
| Rubus fruticosus, iris germanica, vaccinium myrtillus, syzygium jambolanum, okoubaka aubrevillei | 60295-0312 | Liquid | Drugs for further processing | March 1, 1992 |
| Sabal serulatum, lycopodium clavatum, pareira brava | 60295-0310 | Liquid | Drugs for further processing | March 1, 1992 |
| Rhamnus purshiana, carduus marianus, taraxacum officinale, chelidonium majus, leptandra virginica, myrica cerifera, berberis vulgaris, natrum sulphuricum, magnesia phosphorica, cuprum metallicum | 60295-0309 | Liquid | Drugs for further processing | March 1, 1992 |
| Echinacea augustifolia, scrophularia nodosa, abrotanum, petroleum, aloe socotrina, mercurius solubilis, crotalus horiidus, thuja occidentalis, lachesis mutus, aristolochia clematitis | 60295-0305 | Liquid | Drugs for further processing | March 1, 1992 |
| Formicum acidum, lachesis mutus, luffa operculata. petroleum, rhus toxicodebdron, aralai racemosa,galphimia glauca, thuja occidentalis, urtica dicica and cardiospermum | 60295-0304 | Liquid | Drugs for further processing | March 1, 1992 |
| Echinacea angustifolia, hamammelis virginiana, calcarea phosphorica, hydrastis canadanesis, senega officinalis, silicea, conium, aurum muriaticum natronatum, calcarea carbonica, fucus vesiculosus, lachesis mutus | 60295-0101 | Tablet, orally disintegrating | Drugs for further processing | March 1, 1992 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.